Internal Medicine – Page 12

Strengthening the Patient Voice: New Guidance for Qualitative Research in Internal Medicine

By MedXY 03/17/2026

This article outlines new expert consensus on conducting rigorous qualitative research in internal medicine, providing a roadmap for investigators to move beyond numbers and capture the human experience of healthcare through methods like interviews and the Group Medical Visits model.

Clinical Updates Internal Medicine news Respiratory

Prophylactic Haemostatic Strategies in Endobronchial Biopsy: Insights from the PROTECT Trial and Modern Bronchoscopic Practice

By MedXY 03/16/2026

This review evaluates the evidence for prophylactic haemostasis during endobronchial biopsy, centered on the PROTECT trial results, while integrating contemporary data on procedural safety, pre-procedural screening, and technical optimization.

Infectious Diseases Internal Medicine news

Metformin and Ursodeoxycholic Acid Fail to Improve Post-COVID Recovery: Insights from a Randomized Controlled Trial

By MedXY 03/13/2026

A randomized clinical trial indicates that neither metformin nor ursodeoxycholic acid (UDCA) significantly improves recovery from postacute sequelae of SARS-CoV-2 (PASC) compared to placebo, highlighting the ongoing challenge of finding effective treatments for Long COVID.

Diabetes & Endocrinology Internal Medicine news

Relacorilant Demonstrates Sustained Efficacy in Hypertension Control for Patients with Cushing’s Syndrome: Results from the Phase 3 GRACE Study

By MedXY 03/12/2026

The Phase 3 GRACE trial demonstrates that relacorilant, a selective glucocorticoid receptor modulator, significantly maintains hypertension control in patients with Cushing’s syndrome without the safety concerns associated with non-selective antagonists, such as adrenal insufficiency or hypokalemia.

Cardiology Internal Medicine news

TRIM28: A Novel E3 Ubiquitin Ligase Guarding the Heart Against Ischemia/Reperfusion-Induced Ferroptosis

By MedXY 03/12/2026

New research identifies TRIM28 as a critical E3 ubiquitin ligase that degrades IRP2, thereby suppressing iron uptake and preventing myocardial ferroptosis during ischemia/reperfusion injury. This pathway, activated by p55γ and the drug perhexiline, offers a promising therapeutic target for patients with ischemic heart disease.

Cardiology Internal Medicine news

Predicting Heart Failure Before It Starts: The New SCORE2-HF Model and Clinical Consensus for Cardiovascular Risk Assessment

By MedXY 03/11/2026

This article details the SCORE2-HF risk model, a newly validated tool designed to estimate 10-year and 30-year heart failure risks in asymptomatic individuals, enabling earlier intervention and personalized cardiovascular care across diverse European risk regions.

Clinical Updates Internal Medicine news Rehabilitation Medicine

Gut-Muscle Axis: Roseburia inulinivorans as a Novel Mediator of Skeletal Muscle Strength and Fiber-Type Composition

By MedXY 03/11/2026

This clinical update synthesizes evidence on Roseburia inulinivorans, identifying it as a species-specific gut microbe that enhances muscle strength by modulating amino acid metabolism and skeletal muscle fiber types.

Clinical Updates Gastroenterology Internal Medicine news

Targeted Gut-Liver Axis Modulation: The Therapeutic Potential of Gut-Restricted LXR Agonists in Short Bowel Syndrome

By MedXY 03/11/2026

This review explores the development of WUSTL0717, a gut-restricted LXR agonist that mitigates liver injury in short bowel syndrome by leveraging the intestinal HDL-ApoA1 pathway without inducing systemic metabolic complications.

Diabetes & Endocrinology Internal Medicine news

OGTT-Derived Surrogate Indexes Outperform Fasting Measures in Predicting Type 2 Diabetes Risk: A Longitudinal Analysis

By MedXY 03/10/2026

A longitudinal study of 2,260 participants confirms that oral glucose tolerance test (OGTT)-based surrogate indexes, particularly Gutt and Cederholm, are superior to fasting-only measures in predicting type 2 diabetes, providing high clinical utility for metabolic risk stratification.

Cardiology Internal Medicine news

Varenicline and Ventricular Ectopy After Myocardial Infarction: A Randomized Phase 2 Study

By MedXY 03/09/2026

This phase 2 trial demonstrates that varenicline, a partial nAChR agonist, significantly reduces premature ventricular complexes and nonsustained ventricular tachycardia in post-myocardial infarction patients, offering a novel therapeutic target for cardiac arrhythmias.

Diabetes & Endocrinology Internal Medicine news

High-Intensity Interval Training Restores Mitochondrial Architecture in Type 2 Diabetes via Cristae Remodeling

By MedXY 03/09/2026

A breakthrough study demonstrates that high-intensity interval training (HIIT) significantly enhances mitochondrial cristae density and surface area in men with type 2 diabetes, revealing remarkable plasticity in muscle ultrastructure despite metabolic disease.

Cardiology Internal Medicine news

Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac Amyloidosis

By MedXY 03/07/2026

This large retrospective study of 820 patients reveals that restrictive ventricular physiology is the most common phenotype in cardiac amyloidosis. While preserved LV function offers better initial survival, the rate of progression to restriction is high, emphasizing the need for early clinical detection.

Gastroenterology Internal Medicine news

More is Not Always Better: The GOULASH Trial Challenges High-Energy Early Nutrition in Acute Pancreatitis

By MedXY 03/07/2026

The multicentre GOULASH trial reveals that high-energy nutrition in the early phase of acute pancreatitis does not improve outcomes and may increase risks of organ failure and pain relapse compared to a gradual caloric increase, leading to the trial's early termination for futility.

Cardiology Internal Medicine news

The Silent Genetic Threat: Why Most Patients with Familial Hypercholesterolemia Are Still Falling Through the Clinical Cracks

By MedXY 03/06/2026

A massive cohort study of 245,388 US adults reveals that 1 in 287 carries a familial hypercholesterolemia mutation. Despite high risks for premature heart disease, most carriers remain undertreated, with fewer than 20% of those with established disease reaching LDL-C targets.

Diabetes & Endocrinology Internal Medicine news

Orforglipron Demonstrates Superior HbA1c Reduction Over Oral Semaglutide in Type 2 Diabetes: Results from the ACHIEVE-3 Trial

By MedXY 03/06/2026

The ACHIEVE-3 phase 3 trial demonstrates that orforglipron, a novel non-peptide oral GLP-1 receptor agonist, provides superior glycemic control compared to oral semaglutide in adults with type 2 diabetes, despite a higher frequency of gastrointestinal adverse events.

Cardiology Internal Medicine news

ACTA2 Pathogenic Variants: Unmasking the Link Between Smooth Muscle Cell Stress and Early-Onset Atherosclerosis

By MedXY 03/03/2026

Recent research identifies a specific molecular pathway—driven by HSF1 activation and increased cholesterol biosynthesis in smooth muscle cells—that explains why certain ACTA2 mutations predispose patients to premature atherosclerotic cardiovascular disease beyond traditional aortic risks.

Cardiology Internal Medicine news

Beyond Peripheral Blood: Why Biopsy is the Gold Standard for Acute Eosinophilic Myocarditis

By MedXY 03/02/2026

A landmark multicenter study of 156 patients reveals that acute eosinophilic myocarditis frequently presents without peripheral eosinophilia, carries a high risk of death or heart transplant, and requires early immunosuppressive therapy to improve clinical outcomes.

Cardiology Internal Medicine news

Long-Term Prognosis of Acute Myocardial Infarction Caused by Isolated Diffuse Coronary Artery Ectasia

By MedXY 03/02/2026

Patients with myocardial infarction due to isolated coronary artery ectasia face a significantly higher risk of recurrent MI and stent thrombosis compared to those without ectasia, highlighting the need for specialized long-term management.

Diabetes & Endocrinology Internal Medicine news

Women Achieve Greater Weight Loss With GLP-1 Receptor Agonists: A Comprehensive Meta-Analysis of Treatment Heterogeneity

By MedXY 03/02/2026

A systematic review and meta-analysis of 64 randomized trials reveals that GLP-1 receptor agonists lead to significantly higher weight loss in women (10.9%) compared to men (6.8%), while maintaining consistent efficacy across various ages, races, and baseline BMI levels.

Cardiology Internal Medicine news

Beyond the Restrictive Paradigm: Redefining Left Ventricular Phenotypes and Prognosis in Cardiac Amyloidosis

By MedXY 03/02/2026

A large-scale retrospective study challenges the classic view of cardiac amyloidosis, revealing that while restriction is the dominant phenotype at diagnosis, nearly one-third of patients present with preserved function, and progression patterns differ significantly between TTR and AL subtypes.